VCCC Alliance Precision Oncology Forum

Clinical implications of comprehensive molecular testing

18 Aug 2023

The VCCC PRECISION study has aided the establishment of an optimised local genomic testing infrastructure and assesses clinical utility in patients with advanced solid tumours.

In this Precision Oncology Forum, Dr Sathya Manoharan will provide the latest findings from VCCC PRECISION. Dr Stephen Luen will also provide updates on the IMPARP-HRD study.

Aim: To discuss the clinical implications of comprehensive molecular testing in patients with advanced solid tumours using the VCCC PRECISION study.

Learning objective: In this session, you will gain a greater insight into the latest findings from VCCC PRECISION and the IMPARP-HRD study

Content warning: The VCCC Alliance Precision Oncology Forum is aimed primarily at a clinical audience and features open discussion about real cases and patients. While these cases are de-identified, the imagery, content and discussion can be graphic.